Sign up for product news & updates
Koya In the News
Koya Medical Raises New Capital with OrbiMed to Support Growth
Today OrbiMed announced the closing of a financing for up to $30 million to support Koya's strategic expansion and continued growth.
Koya Medical Selected for Poster Presentation of the NILE Clinical Trial, awarded Gold medal at AMCP 2023
Koya Medical today announced their selection for a poster presentation of the NILE Trial at the upcoming AMCP conference.
Koya Medical Announces the Addition of Chief Medical Officer Dr. Thomas Maldonado to Their Executive Leadership Team
The addition of Dr. Maldonado further strengthens Koya Medical’s clinical advisory board, led by Stanley Rockson, M.D.
Koya Medical Presents Two Newly Published Clinical Studies for Dayspring Active Compression Treatments for Lymphedema and Venous Disease at the AVLS 2022 Annual Congress
Koya Medical presented two newly published clinical studies for the treatment of lymphedema and venous disease with its Dayspring active compression
Koya Medical Announces Two Clinical Data Publications for Dayspring® Active Compression Treatments for Lymphedema and Venous Disease
Published Studies Reveal New Data About Edema Reduction,Patient Satisfaction and Quality of Life With Dayspring System
Koya Medical Launches Dayspring Lower Extremity Active Compression Treatments for Lymphedema and Venous Disorders
Koya Medical Launches Dayspring Lower Extremity Active Compression Treatments and CMS Issues Three New Billing Codes
Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies for Lymphedema and Venous Disorders
Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Treatments for Lymphedema and Venous Disorders
Reimagining Compression Therapy for Lymphedema and Venous Disease: A Podcast with Outcomes Rocket MedTech
Outcomes Rocket Podcast: Founder Discusses Treatment Gaps in Lymphedema and Koya Medical's Innovative Dayspring Treatment
Koya Medical Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression
Interim data presented at American Vein and Lymphatic Society Annual Congress show reduction in limb volume, improved quality of life and adherence.
Koya Medical and Essity Sponsor Forum for Physicians, Lymphedema Therapists and Researchers to Discuss Health
Space Forum Dinner discusses the implications of weightlessness in space travel on the lymphatic and venous systems and human adaptability
Koya Medical Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms
CMS issues new HCPCS codes for Dayspring, a novel wearable active compression treatment for lymphedema and venous diseases.
Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities
Dayspring is now FDA cleared for lymphedema and venous disease treatment in both upper and lower extremities. Koya Medical also grows leadership team.
Koya to Present at Oppenheimer MedTech, Tools & Diagnostics Summit
Join CEO and President Andy Doraiswamy, Ph.D., as he provides an overview of recent business milestones and developments with Dayspring™ on May 26th.
Ali Bauerlein Joins Koya Medical Board of Directors
Medical technology leader brings over 20 years of experience and a strong history of building shareholder value in the healthcare domain.
Get in touch with us to schedule a demo